
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Stay tuned for a campaign blitz promoting the adoption of shelter animals starting Sept. 21.
Stay tuned for a campaign blitz promoting the adoption of shelter animals starting Sept. 21.





